InsightfulValue
← Home

Bristol Myers Squibb
Bristol Myers Squibb

-12.98%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
🧩 Revenue Segmentation by Product

Switch to Location
Fiscal year Segment Value
2025 Sotyktu 291M
2025 Breyanzi 1.36B
2025 Sprycel 493M
2025 Eliquis 14.44B
2025 Opdivo Ovantig 238M
2025 Pomalyst/Imnovid 2.73B
2025 Zeposia 577M
2025 Abecma 427M
2025 Reblozyl 2.33B
Bristol Myers Squibb

πŸ’° Explore more revenue segmentation data for Bristol Myers Squibb!

Sign up for free or log in

πŸ“ Join us and grab your copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal